The FDA cleared the Epithelial Thickness Module for the Anterion cornea app from Heidelberg Engineering, according to a press ...

The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

The Epithelial Thickness Module is expected to be commercially available in February 2025. According to Heidelberg ...

Doctors have devised a way of building a new retinal pigment epithelium and surgically implanting it into the eye. The technique, published in Nature Biotechnology, starts with embryonic stem cells.

Traditional treatments often involve grafts from the patient's healthy eye or donors ... "Induced pluripotent stem-cell-derived corneal epithelium for transplant surgery: a single-arm, open ...

noninvasive corneal cross-linking drug therapy that does not require removal of the corneal epithelium, the outermost layer of the front of the eye,” Thomas Burns, chairman and CEO of Glaukos ...